Company intelligence / Profile preview
ENBIOSIS Biotechnology
London, England, United Kingdomenbiosis.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Commercial
01
Overview
ENBIOSIS has demonstrated clinically validated results with its AI-powered personalized nutrition platform—showing measurable improvements in symptoms of IBS (~78% success) and chronic constipation (~83% success) through dietary modulation of the gut microbiome. The company’s liquid-biopsy diagnostic products are non-invasive tools under active research/development. Its technology has been recognized by top-tier journals and awards within the field.
- Therapeutic areas
- Gastroenterology
- Modalities
- Microbiome-based diagnostics and therapeutics (including prebiotics/probiotics)AI-driven personalized nutrition and supplement recommendationsLiquid biopsy biomarkers for early disease detectionBacteriophage therapy (in development)Smart microbiome transplant (in development)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Collaborations with academic institutions in Medicon Valley regionstrategic partnerships with healthcare providers/practitioners internationallysupported by UK government grants/funding initiatives.
Beyond the preview
Go deeper on ENBIOSIS Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ENBIOSIS Biotechnology.